Yifeng Pharmacy Chain Co., Ltd. (SHA:603939)
China flag China · Delayed Price · Currency is CNY
26.65
+0.04 (0.15%)
Nov 18, 2026, 3:00 PM CST

Yifeng Pharmacy Chain Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,8061,6781,5291,4121,262887.88
Depreciation & Amortization
1,7241,7241,8831,6491,4411,191
Other Amortization
239.34239.34264.93182.97145.38117.19
Loss (Gain) From Sale of Assets
-65.46-65.46-46.1-29.09-12.84-6.85
Asset Writedown & Restructuring Costs
14.1214.1218.83--1.43
Loss (Gain) From Sale of Investments
-124.75-124.75-108.13-42.37-6.87-34.37
Provision & Write-off of Bad Debts
0.040.04-2.154.5410.474.41
Other Operating Activities
789.45399.78381.92402.11382.81313.34
Change in Accounts Receivable
169.26169.26-554.45-258.28-1,013-600.7
Change in Inventory
-206.45-206.45-790.97-261.54-459.39-885.07
Change in Accounts Payable
-447.32-447.321,5931,5432,1401,177
Change in Other Net Operating Assets
-21.78-21.7865.4242.423.1619.27
Operating Cash Flow
3,8763,3584,2214,6243,9202,150
Operating Cash Flow Growth
23.18%-20.44%-8.71%17.95%82.34%-7.71%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-320.04-322.92-682.67-739.92-587.51-827.54
Sale of Property, Plant & Equipment
25.6124.1866.2715.789.036.52
Cash Acquisitions
-42.67-136.62-254.66-498.82-450.56-408.88
Divestitures
-1.2----
Investment in Securities
-1,545-1,111-2,811-1,781-250.05632
Other Investing Activities
1,479118.8473.5123.915.0831.06
Investing Cash Flow
-403.2-1,426-3,609-2,980-1,274-566.84

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--1,814-80142.12
Long-Term Debt Repaid
--1,554-1,780-1,687-1,483-2,083
Lease Payments
-1,462-1,462-1,605-1,603-1,352-1,236
Net Debt Issued (Repaid)
-1,482-1,55433.55-1,687-1,403-1,940
Issuance of Common Stock
---7.3977.41-
Repurchase of Common Stock
-0.66-0.66-4-3.52-2.85-1.69
Common Dividends Paid
-846.43-849.31-846.54-321.88-235.02-211.89
Other Financing Activities
-67.69-76.12-103.21-87.91-91.56-30.96
Financing Cash Flow
-2,397-2,480-920.2-2,093-1,655-2,185

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
1,076-547.53-307.78-449.62991-601.88

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,5563,0363,5393,8843,3331,322
Free Cash Flow Growth
32.90%-14.22%-8.89%16.53%152.02%-24.30%
Free Cash Flow Margin
14.01%12.42%14.71%17.19%16.76%8.63%
Free Cash Flow Per Share
2.872.462.873.222.751.10
Levered Free Cash Flow
3,4942,5273,2333,2033,1231,096
Unlevered Free Cash Flow
3,5702,6323,3713,3043,2261,201
Free Cash Flow After Leases
2,0941,5731,9342,2811,98186.43

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
1,5911,3631,3281,3081,053746.51
Change in Working Capital
-507.19-507.19300.791,045698.37-324.56